Showing results (401-410 of 1,273) with videos related to
Sort By:
Pageof 128
JACC. Cardiovascular Interventions|September 24, 2016
Correlates and Impact of Coronary Artery Calcifications in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) CollaborationGennaro Giustino, Ioannis Mastoris, Usman Baber, et al.Circulation. Cardiovascular Interventions|July 11, 2019
Impact of Diabetes Mellitus in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting StentsUsman Baber, Giulio G Stefanini, Gennaro Giustino, et al.JACC. Cardiovascular Interventions|January 6, 2018
Effect of Increasing Stent Length on 3-Year Clinical Outcomes in Women Undergoing Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents: Patient-Level Pooled Analysis of Randomized Trials From the WIN-DES InitiativeJaya Chandrasekhar, Usman Baber, Samantha Sartori, et al.JACC. Cardiovascular Interventions|January 15, 2016
Effect of Chronic Kidney Disease in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: A Patient-Level Pooled Analysis of Randomized Controlled TrialsUsman Baber, Gennaro Giustino, Samantha Sartori, et al.European Heart Journal|February 25, 2005
Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcomePeter Wenaweser, Christoph Rey, Franz R Eberli, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 26, 2015
Long-term ticagrelor monotherapy versus standard dual antiplatelet therapy followed by aspirin monotherapy in patients undergoing biolimus-eluting stent implantation: rationale and design of the GLOBAL LEADERS trialPascal Vranckx, Marco Valgimigli, Stephan Windecker, et al.American Heart Journal|September 1, 2014
Randomized comparison of biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for percutaneous coronary revascularization: rationale and design of the BIOSCIENCE trialThomas Pilgrim, Marco Roffi, David Tüller, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 6, 2020
Impact of individual stroke risk on outcome after Amplatzer left atrial appendage closure in patients with atrial fibrillationJonas D Häner, Monika Fürholz, Caroline Kleinecke, et al.Journal of the American Heart Association|September 28, 2021
Incidence and Outcomes of Infective Endocarditis After Transcatheter or Surgical Aortic Valve ReplacementJonas Lanz, Michael J Reardon, Thomas Pilgrim, et al.Scientific Reports|September 22, 2021
Deep learning-based prediction of early cerebrovascular events after transcatheter aortic valve replacementTaishi Okuno, Pavel Overtchouk, Masahiko Asami, et al.Pageof 128